91³Ô¹ÏÍø

Research & Innovation Office (RIO)—91³Ô¹ÏÍø announced seven winners of the 2023-2024 translational quantum research seed grants, incentivizing quantum science and technology innovations launched from the lab to accelerate them along the

91³Ô¹ÏÍø Today—The world must slash greenhouse gas emissions to nearly zero by 2050. To reach this goal, technological innovations that can help reduce emissions from the source or absorb emitted warming gasses are crucial. Here's a look at four innovations 91³Ô¹ÏÍø researchers are working on today.

Sixteen teams of University of Colorado faculty, researchers and graduate student innovators competed for a combined $1.5 million in startup funding grants.

Camila Uzcategui's venture into 3D printing resulted from a desire to contribute to global healthcare significantly. Through her experiences in NGOs and nonprofits, she identified a glaring need for essential medical devices in health clinics, sowing the seeds for her exploration into additive manufacturing.

College of Arts and Sciences—91³Ô¹ÏÍø researcher Karolin Luger, a distinguished professor of biochemistry and Jennie Smoly Caruthers Endowed Chair of Biochemistry, has been awarded the 2023 World Laureates Association Prize in Life Science or Medicine.

The Embark Deep Tech Startup Creator at Venture Partners at 91³Ô¹ÏÍø has officially launched its first Embark Entrepreneurs in Residence cohort. Embark aims to connect business minds outside the university with breakthrough inventions emerging from 91³Ô¹ÏÍø's research labs to bring them to market and unleash the full impact of 91³Ô¹ÏÍø's research into the world.

College of Engineering and Applied Science—Srubar's lab conducts major research into biomimetic and living materials that have the potential to drastically reduce environmental pollution caused by construction activities around the globe.

College of Engineering and Applied Science—Svenja Knappe and her colleagues have developed a helmet that contains 128 sensors and is customizable for different sizes of the human head. Knappe founded the Boulder-based company FieldLine and has begun to bring these sensors to market. In the not-so-distant future, they could aid in the diagnosis and treatment of a wide range of neurological conditions like epilepsy, autism and traumatic brain injuries.

91³Ô¹ÏÍø Today—Chemists at 91³Ô¹ÏÍø have developed a new way to recycle a common type of plastic found in soda bottles and other packaging and are working with Venture Partners at 91³Ô¹ÏÍø to bring it to real-world applications. The team’s method relies on electricity and some nifty chemical reactions, and it’s simple enough that you can watch the plastic break apart in front of your eyes.

91³Ô¹ÏÍø Today—In 2016, Pfizer began collaborating with Sabrina Spencer, a global leader in time-lapse cell imaging and member of the CU Cancer Center, to study how cancer cells respond to their potent new drugs called CDK2 inhibitors.